J. Bertram

979 total citations
26 papers, 755 citations indexed

About

J. Bertram is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, J. Bertram has authored 26 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in J. Bertram's work include RNA and protein synthesis mechanisms (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Platelet Disorders and Treatments (3 papers). J. Bertram is often cited by papers focused on RNA and protein synthesis mechanisms (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Platelet Disorders and Treatments (3 papers). J. Bertram collaborates with scholars based in Germany, United States and Australia. J. Bertram's co-authors include Michael Kneba, Wolfgang Hiddemann, Michael Strätz, Peter Dürre, Wolfgang Hiddemann, G. Gottschalk, I Bolz, Burkhard Linke, Anita Kuhn and Gerhard Gottschalk and has published in prestigious journals such as Blood, Journal of Bacteriology and European Journal of Cancer.

In The Last Decade

J. Bertram

25 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Bertram Germany 13 452 129 103 97 86 26 755
Samantha Bennett United Kingdom 14 734 1.6× 197 1.5× 104 1.0× 109 1.1× 57 0.7× 15 1.2k
Jeffrey W. Craig United States 13 459 1.0× 139 1.1× 86 0.8× 105 1.1× 58 0.7× 54 807
Alexander Jacobi Germany 10 428 0.9× 50 0.4× 53 0.5× 41 0.4× 113 1.3× 12 892
Gaëlle Rondeau United States 16 339 0.8× 65 0.5× 56 0.5× 36 0.4× 40 0.5× 21 599
G. Shanmugam India 24 846 1.9× 248 1.9× 50 0.5× 48 0.5× 270 3.1× 76 1.5k
Michel Heusterspreute Belgium 17 546 1.2× 113 0.9× 49 0.5× 28 0.3× 271 3.2× 31 1.0k
Jihong Yang China 18 557 1.2× 103 0.8× 398 3.9× 44 0.5× 78 0.9× 48 1.2k
Zhiyong Xiong China 20 881 1.9× 108 0.8× 88 0.9× 37 0.4× 50 0.6× 50 1.3k
Tongrui Liu United States 14 583 1.3× 343 2.7× 69 0.7× 34 0.4× 46 0.5× 31 1.1k
Chi Ho Lin Hong Kong 15 1.2k 2.7× 225 1.7× 161 1.6× 38 0.4× 93 1.1× 19 1.8k

Countries citing papers authored by J. Bertram

Since Specialization
Citations

This map shows the geographic impact of J. Bertram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Bertram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Bertram more than expected).

Fields of papers citing papers by J. Bertram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Bertram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Bertram. The network helps show where J. Bertram may publish in the future.

Co-authorship network of co-authors of J. Bertram

This figure shows the co-authorship network connecting the top 25 collaborators of J. Bertram. A scholar is included among the top collaborators of J. Bertram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Bertram. J. Bertram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tremante, Elisa, Leonardo Sibilio, Gerhard A. Holzapfel, et al.. (2021). TOOLBOX: Strep‑Tagged nano‑assemblies of antibody‑drug‑conjugates (ADC) for modular and conditional cancer drugging. Oncology Reports. 45(5). 4 indexed citations
2.
Lemke, Karen, et al.. (2008). Protein‐Processing Platform (3P) – a New Concept for the Characterization of Cell Cultures in the mL‐Scale Using Microfluidic Components. Engineering in Life Sciences. 8(1). 73–80. 1 indexed citations
3.
Bertram, J.. (2006). MATra - Magnet Assisted Transfection: Combining Nanotechnology and Magnetic Forces to Improve Intracellular Delivery of Nucleic Acids. Current Pharmaceutical Biotechnology. 7(4). 277–285. 12 indexed citations
4.
Lemke, Karen, et al.. (2004). Protein‐Prozessierungs‐Plattform – Ein neues System zur Charakterisierung parallelisierter und miniaturisierter Bioprozesse. Chemie Ingenieur Technik. 76(9). 1233–1234. 1 indexed citations
5.
Berkovic, Dinko, J. Bertram, Timo Wille, et al.. (2001). Effects of hexadecylphosphocholine on thrombocytopoiesis. European Journal of Cancer. 37(4). 503–511. 8 indexed citations
6.
Beyer-Sehlmeyer, Gabriele, Wolfgang Hiddemann, Bernhard Wörmann, & J. Bertram. (1999). Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin. European Journal of Cancer. 35(12). 1735–1742. 28 indexed citations
7.
Bertram, J., et al.. (1998). Elevated expression of S100P, CAPL and MAGE 3 in doxorubicin-resistant cell lines. Anti-Cancer Drugs. 9(4). 311–318. 70 indexed citations
9.
Bertram, J., et al.. (1997). Cardiac phase-synchronized myocardial thallium-201 single-photon emission tomography using list mode data acquisition and iterative tomographic reconstruction. European Journal of Nuclear Medicine and Molecular Imaging. 24(3). 276–280. 1 indexed citations
10.
Linke, Burkhard, I Bolz, Afshin Fayyazi, et al.. (1997). Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes. Leukemia. 11(7). 1055–1062. 55 indexed citations
11.
Bertram, J., et al.. (1996). Increase of P-glycoprotein-mediated drug resistance by hsp 90b. Anti-Cancer Drugs. 7(8). 838–845. 40 indexed citations
12.
Kneba, Michael, et al.. (1995). Improvement of Hammerhead Ribozymes Cleavingmdr-1mRNA. Biological Chemistry Hoppe-Seyler. 376(5). 289–296. 11 indexed citations
13.
Bertram, J., et al.. (1995). Reversal of multiple drug resistance in vitro by phosphorothioate oligonucleotides and ribozymes. Anti-Cancer Drugs. 6(1). 124–134. 29 indexed citations
14.
Kneba, Michael, et al.. (1995). Short technical reports. Quantification of ribozyme-mediated RNA cleavage using silver-stained polyacrylamide gels.. PubMed. 19(6). 926–9. 10 indexed citations
16.
McGrath, Kathy, et al.. (1992). Amphotericin B‐induced injury in stored human platelets. Transfusion. 32(1). 46–50. 12 indexed citations
17.
Bertram, J., et al.. (1992). Isopropylbenzene (cumene) ? a new substrate for the isolation of trichloroethene-degrading bacteria. Archives of Microbiology. 158(1). 9–13. 49 indexed citations
18.
Bertram, J., et al.. (1989). Purification and characterization of the pyruvate-ferredoxin oxidoreductase from Clostridium acetobutylicum. Archives of Microbiology. 152(3). 244–250. 73 indexed citations
19.
Bertram, J., et al.. (1981). Effects of N-acetyl glucosamine on platelet aggregation. Thrombosis Research. 23(3). 289–300. 1 indexed citations
20.
Bertram, J., et al.. (1981). The effects of glucosamine on platelet aggregation. Thrombosis Research. 23(3). 301–307. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026